Shiyu Capital Leads $278M Series A Round In Chinese Pharmaceutical Startup Mabwell
April 29, 2020 — 17:19 CST
This Data Is Locked!
This area is available only to Subscribers.
Chinese venture capital firm Shiyu Capital has led a RMB1.97 billion (US$278.5 million) Series A financing round in Mabwell Biotech, a Shanghai-based innovative biopharmaceutical company.... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals